These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
599 related articles for article (PubMed ID: 24292552)
41. Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks. Arendt M; Nasir L; Morgan IM Vet Comp Oncol; 2009 Sep; 7(3):153-61. PubMed ID: 19691644 [TBL] [Abstract][Full Text] [Related]
43. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges. Liu H; Luo H Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859 [TBL] [Abstract][Full Text] [Related]
44. Clinical development of oncolytic viruses in China. Liang M Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357 [TBL] [Abstract][Full Text] [Related]
45. Thunder and lightning: immunotherapy and oncolytic viruses collide. Melcher A; Parato K; Rooney CM; Bell JC Mol Ther; 2011 Jun; 19(6):1008-16. PubMed ID: 21505424 [TBL] [Abstract][Full Text] [Related]
46. Viruses for tumor therapy. Bell J; McFadden G Cell Host Microbe; 2014 Mar; 15(3):260-5. PubMed ID: 24629333 [TBL] [Abstract][Full Text] [Related]
47. Potential and clinical translation of oncolytic measles viruses. Robinson S; Galanis E Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716 [TBL] [Abstract][Full Text] [Related]
48. Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy? Naik JD; Twelves CJ; Selby PJ; Vile RG; Chester JD Clin Cancer Res; 2011 Jul; 17(13):4214-24. PubMed ID: 21576084 [TBL] [Abstract][Full Text] [Related]
49. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy. Zhang B; Cheng P Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438 [TBL] [Abstract][Full Text] [Related]
50. Oncolytic Virotherapy for Breast Cancer Treatment. O Bryan SM; Mathis JM Curr Gene Ther; 2018; 18(4):192-205. PubMed ID: 30207220 [TBL] [Abstract][Full Text] [Related]
51. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy. Lal G; Rajala MS Cancer Gene Ther; 2018 Oct; 25(9-10):216-226. PubMed ID: 29735993 [TBL] [Abstract][Full Text] [Related]
52. Novel oncolytic viruses: riding high on the next wave? Stanford MM; Bell JC; Vähä-Koskela MJ Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409 [TBL] [Abstract][Full Text] [Related]
53. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions. Liu TC; Kirn D Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747 [TBL] [Abstract][Full Text] [Related]